GC Pharma's Barycela challenges the international procurement market. Competition among domestic companies in the international procurement market for chickenpox virus vaccines is likely to begin in earnest. SK Bioscience seems to be challenging first while undergoing the World Health Organization (WHO) certification process for overseas sales of GC Pharma's new chickenpox vaccine. According to the industry on the 15th, SK Bioscience made its debut in the international procurement market for chickenpox vaccines on the 14th. SK Bioscience received a preliminary notice from PAHO about $31.27 million worth of chickenpox vaccine orders.

SK Bioscience will supply Sky Varicella, a chickenpox vaccine, to the L